Search research articles
Contact Us
Filters
Showing results (371-380 of 611) with videos related to
Page
of 62
Sort By:
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
April 6, 2007
Limitations of acceptability curves for presenting uncertainty in cost-effectiveness analysis
Bas Groot Koerkamp, M G Myriam Hunink, Theo Stijnen, et al.
Journal of the American College of Cardiology
|
October 5, 2001
The effect of risk factor reductions between 1981 and 1990 on coronary heart disease incidence, prevalence, mortality and cost
L Goldman, K A Phillips, P Coxson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 16, 2011
Calibrating longitudinal models to cross-sectional data: the effect of temporal changes in health practices
Douglas C A Taylor, Vivek Pawar, Denise Kruzikas, et al.
American Heart Journal
|
June 8, 2019
Modeling the cost effectiveness and budgetary impact of Polypills for secondary prevention of cardiovascular disease in the United States
Thomas A Gaziano, Ankur Pandya, Stephen Sy, et al.
JAMA
|
May 26, 1999
The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men
S J Goldie, K M Kuntz, M C Weinstein, et al.
Clinical Genetics
|
April 3, 1999
Mutations associated with very late-onset metachromatic leukodystrophy
C Perusi, M G Lira, R F Duyff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 3, 2004
HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysis
Elena B Elkin, Milton C Weinstein, Eric P Winer, et al.
Journal of the National Cancer Institute
|
April 22, 2004
Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine
Sue J Goldie, Michele Kohli, Daniel Grima, et al.
BMC Infectious Diseases
|
May 22, 2013
Impact of 13-valent pneumococcal conjugate vaccine (PCV13) in a pandemic similar to the 2009 H1N1 in the United States
Lisa J McGarry, Kristen E Gilmore, Jaime L Rubin, et al.
Substance Use & Misuse
|
March 29, 2023
A Qualitative Analysis of Hospitalist Perceptions of Self-Directed Discharge Among Inpatients with Opioid Use Disorder
Megan K Reed, Nazanin Sarpoulaki, Vignesh Murali, et al.
Page
of 62
Search research articles
Search
Showing results (371-380 of 611) with videos related to
Sort By:
Page
of 62
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
April 6, 2007
Limitations of acceptability curves for presenting uncertainty in cost-effectiveness analysis
Bas Groot Koerkamp, M G Myriam Hunink, Theo Stijnen, et al.
Journal of the American College of Cardiology
|
October 5, 2001
The effect of risk factor reductions between 1981 and 1990 on coronary heart disease incidence, prevalence, mortality and cost
L Goldman, K A Phillips, P Coxson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 16, 2011
Calibrating longitudinal models to cross-sectional data: the effect of temporal changes in health practices
Douglas C A Taylor, Vivek Pawar, Denise Kruzikas, et al.
American Heart Journal
|
June 8, 2019
Modeling the cost effectiveness and budgetary impact of Polypills for secondary prevention of cardiovascular disease in the United States
Thomas A Gaziano, Ankur Pandya, Stephen Sy, et al.
JAMA
|
May 26, 1999
The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men
S J Goldie, K M Kuntz, M C Weinstein, et al.
Clinical Genetics
|
April 3, 1999
Mutations associated with very late-onset metachromatic leukodystrophy
C Perusi, M G Lira, R F Duyff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 3, 2004
HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysis
Elena B Elkin, Milton C Weinstein, Eric P Winer, et al.
Journal of the National Cancer Institute
|
April 22, 2004
Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine
Sue J Goldie, Michele Kohli, Daniel Grima, et al.
BMC Infectious Diseases
|
May 22, 2013
Impact of 13-valent pneumococcal conjugate vaccine (PCV13) in a pandemic similar to the 2009 H1N1 in the United States
Lisa J McGarry, Kristen E Gilmore, Jaime L Rubin, et al.
Substance Use & Misuse
|
March 29, 2023
A Qualitative Analysis of Hospitalist Perceptions of Self-Directed Discharge Among Inpatients with Opioid Use Disorder
Megan K Reed, Nazanin Sarpoulaki, Vignesh Murali, et al.
Page
of 62